Cellular uptake of fluvastatin, an inhibitor of HMG-CoA reductase, by rat cultured hepatocytes and human aortic endothelial cells.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  1999-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/J.1365-2125.1999.00901.XPMID 10233202PMCID PMC2014242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase Inhibitors

  1997cited by this paper
• Inhibitory effect of fluvastatin at doses insufficient to lower serum lipids on the catheter-induced thickening of intima in rabbit femoral artery.

  1996cited by this paper
• Metabolic Fate of Fluvastatin, an Inhibitor of HMG-CoA Reductase (1): Absorption, Distribution and Excretion of [14C]Fluvastatin after Single Administration in Rats

  1995cited by this paper
• Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types.

  1995cited by this paper
• Metabolic Fate of Fluvastatin, an Inhibitor of HMG-CoA Reductase (4): Stereoselective Pharmacokinetics of the Enantiomers of Fluvastatin in Rats

  1995cited by this paper
• Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver.

  1993cited by this paper
• Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier.

  1993cited by this paper
• Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture.

  1992cited by this paper
• Uptake of organic anions by isolated rat hepatocytes. A classification in terms of ATP-dependency.

  1992cited by this paper
• Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans.

  1991cited by this paper
• HMG‐CoA Reductase Inhibitors: An Exciting Development in the Treatment of Hyperlipoproteinemia

  1991cited by this paper
• Multispecificity of Na+-dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles.

  1989cited by this paper
• Hepatocellular uptake of organic anions.

  1986cited by this paper
• Driving forces in hepatocellular uptake of phalloidin and cholate.

  1984cited by this paper
• Effects of organic anions on the uptake of 1-anilino-8-naphthalenesulfonate by isolated liver cells.

  1983cited by this paper
• Role of serum in maintenance of functional hepatocytes in primary culture.

  1982cited by this paper
• Interactions between transport inhibitors at the anion binding sites of the band 3 dimer.

  1981cited by this paper
• Effect of Na⊕ on Bile Acid Uptake by Isolated Rat Hepatocytes

  1978cited by this paper
• Effect of organic anions on bile acid uptake by isolated rat hepatocytes.

  1978cited by this paper
• Uptake of bromosulfophthalein by isolated liver cells.

  1976cited by this paper
• Uptake of Bromosulfophthalein byIsolated Liver Cells

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Activation of beef heart mitochondrial adenosine triphosphatase by 2,4-dinitrophenol.

  1973cited by this paper

• Colon targeted Eudragit coated beads loaded with optimized fluvastatin-scorpion venom conjugate as a potential approach for colon cancer therapy: in vitro anticancer activity and in vivo colon imaging.

  2022cites this paper
• Effect of Atorvastatin Treatment on Vascular Aterogenic Factors (Lipid Profiles and VCAM-1) in Patient Diabetes with Dyslipidemia

  2019cites this paper
• Synthesis of deuterium-labeled (3R, 5S)-fluvastatin and (3S, 5R)-fluvastatin

  2018cites this paper
• A Study of Effects on MMP14 Transcriptional Regulation and Angiogenesis by Hypoxia and Statins

  2014cites this paper
• Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.

  2013cites this paper
• Regulation of the Inducible L-Arginine-Nitric Oxide Pathway by Oxidative Stress and Statins

  2010cites this paper
• Update on statin-mediated anti-inflammatory activities in atherosclerosis

  2009cites this paper
• Methods to measure the intracellular concentration of unlabeled compounds within cultured cells using liquid chromatography/tandem mass spectrometry.

  2008cites this paper
• Comparison of different approaches to predict metabolic drug–drug interactions

  2007cites this paper
• HMG-CoA reductase inhibitors: effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol.

  2005cites this paper
• Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients.

  2005cites this paper
• Regional intestinal absorption and biliary excretion of fluvastatin in the rat: possible involvement of mrp2.

  2004cites this paper
• Uptake mechanism of pitavastatin, a new inhibitor of HMG-CoA reductase, in rat hepatocytes.

  2003cites this paper
• Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme a reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipient.

  2003cites this paper
• Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat

  2002cites this paper
• Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation.

  2001cites this paper
• Inhibitory effects of fluvastain and its metabolites on the formation of several reactive oxygen species.

  2001cites this paper
• Quantitative Drug Interactions Prediction System (Q-DIPS)

  2001cites this paper
• Clinical Pharmacokinetics of Cerivastatin

  2000cites this paper
• Carrier-Mediated Uptake of Cerivastatin in Primary Cultured Rat Hepatocytes

  2000cites this paper